By Matthew Phelan March 25, 2022 NEW YORK (Reuters Health) – Inhaled flecainide shows promise for returning patients with recent-onset atrial fibrillation (AF) to sinus rhythm, a new study suggests. This route of administration could shorten the duration of emergency room visits and reduce the volume of hospital admissions, they write in Circulation: Arrhythmia and Electrophysiology. “Oral...